Objective: To evaluate the heart rate (HR) and oxygen saturation (SpO 2 ) at 15-second intervals within 60 seconds after incremental increases of fractional inspired oxygen (FiO 2 ) during resuscitation of infants younger than 29 weeks requiring two different forms of ventilatory support. Study design: Retrospective observational study. Methods: Forty-three infants were stabilized, 14 by continuous positive airway pressure exclusively (CPAP group), and 29 by positive pressure ventilation (PPV group). Both groups received ventilatory support in a special bed with two cameras enabling the evaluation of all interventions including HR, SpO 2 , FiO 2 , positive inflation pressure, and positive end-expiratory pressure values. FiO 2 was commenced at 0.30 and titrated in 0.1e0.2 increments every 30e60 seconds. The relationships between the incremental increases of FiO 2 and related SpO 2 and HR changes were evaluated. Results: Although there was an inverse correlation between initial FiO 2 and SpO 2 in both groups, a significant positive correlation between the incremental increase of FiO 2 and SpO 2 changes after 30 seconds was found only in the CPAP group. Only higher initial levels of FiO 2 had a positive effect on the improvement in SpO 2 in the PPV group. Conclusion: The efficacy of FiO 2 titration in 0.1e0.2 increments may be attenuated and delayed in extremely preterm infants required PPV during the first 6 minutes of life.
Introduction
The latest recommendations of the International Liaison Committee on Resuscitation (ILCOR) were expanded to include the use of pulse oximetry during neonatal resuscitation. 1 However, evidence as to the precise management of supplemental oxygen in premature newborns is currently lacking.
Several small, prospective randomized trials confirmed that resuscitation of extremely premature infants (EPI) may be initiated with lower levels of fractional inspired oxygen (FiO 2 ) between 0.21 and 0.40. 2e4 However, except for one small study reporting a decrease in the incidence of bronchopulmonary dysplasia (BPD) in their low FiO 2 group, there is no evidence favoring these lower FiO 2 values in terms of reduction of adverse long-term outcomes. 5 Wang et al, 2 Escrig et al, 3 and Rabi et al 4 have shown in randomized trials that it is possible to titrate administration of supplemental oxygen to oxygen saturation measurements in newly born preterm infants. More than 80% of infants initially receiving room air subsequently received supplemental oxygen titrated to attain targeted SpO 2 values. 2, 3, 6 These cohorts included premature infants stabilized on continuous positive airway pressure (CPAP) as well as those who required positive pressure ventilation (PPV) or intubation in the delivery room.
Oxygen treatment in a newborn will not be effective if the infant's lungs are not aerated, so the primary step is not oxygen treatment but rather the establishment of functional residual capacity. The strategy of oxygen tailoring, as a secondary step to appropriate gradual oxygenation, is based on evidence from small randomized controlled trials 2e4, 6 and has been recommended as appropriate by experts in the field of delivery room resuscitation. 7, 8 The FiO 2 incremental step of 0.1 every 30e60 seconds being practiced now in ongoing prospective comparative studies such as the premature infants resuscitated with oxygen or air (PRESOX) study and the targeted oxygenation in the resuscitation of premature infants and their developmental outcome (TO2RPIDO) trial. Another study, the room-air versus oxygen administration for resuscitation of preterm infants (ROAR) study, used bigger and quicker FiO 2 increment of 0.2 every 15 seconds to reach a target saturation range. 4 Spontaneously breathing very preterm infants immediately after delivery prolong their expiration by a breath hold to defend lung volume. 9 However, the PPV using the frequencies of 40e60/minute recommended by ILCOR does not allow expiratory braking. 1 This pattern of artificial breathing together with the occurrence of leaks and obstructions may delay uniform lung aeration and establishment of lung volume/alveolar aeration, which may adversely influence the efficacy of supplemental oxygen. 10 There are no clear clinical data that evaluate the efficacy of incremental increases of FiO 2 on the rise of HR and SpO 2 , specifically when comparing two very different EPI groups, namely (1) spontaneously breathing on CPAP exclusively, and (2) not spontaneously breathing and requiring PPV. The two different groups would presumably undergo different mechanisms and dynamics in order to establish their functional residual capacity. We undertook this retrospective analysis to test the hypothesis that infants who are not breathing spontaneously and require PPV will respond less well to incremental increases in FiO 2 than those who have established a better FRC by their spontaneous respiratory effort.
Objectives
The objectives of this study were to evaluate the HR and SpO 2 changes after incremental increases of FiO 2 in newly born extremely preterm infants receiving CPAP versus infants receiving PPV during the first 6 minutes of life.
Patients and methods
This observational study was conducted at the tertiary perinatal center of General Faculty Hospital in Prague, where approximately 4500 infants are delivered and approximately 140 infants <1500 g are admitted into the neonatal intensive care unit annually. In the period from January 2010 to February 2011, delivery room interventions, heart rate, and SpO 2 values were systematically collected from all inborn EPI < 29 weeks to evaluate an internal standardized protocol for resuscitation of EPI. This protocol had been created on a background of current knowledge and evidence. In addition, these prospectively collected data allowed us to analyze our strategy of FiO 2 tailoring retrospectively. All the EPI were placed immediately after delivery onto a specially modified mobile resuscitation warmer bed (ALFAMEDIC sro, Lisov, Czech Republic) with two cameras attached to the frame. One camera recorded all interventions that the patient was receiving on the resuscitaire, whereas the second camera recorded the actual time, pulse oximetry (PO) values, FiO 2 , positive inflation pressure (PIP), and positive endexpiratory pressure (PEEP). Using TRAL software sequence analysis made it possible to concurrently evaluate both of the recorded sequences on one screen. 11 All infants were resuscitated according to a standard protocol and algorithm, and were attended by a team of two doctors and two nurses, one of each having a minimum 10 years of neonatal clinical experience.
Resuscitation procedure
A PO sensor was placed on the right wrist as soon as possible and connected to a PO with a preset 2-second interval (Radical, Masimo, California, USA). Primary settings for the T-piece were as follows: gas flow of 8 L/min, PIP of 26 cmH 2 O, and PEEP of 5 cmH 2 O. The frequency of PPV in the range of 40e60/minutes was suggested and sustained inflation was not routinely used with the initiation of PPV. CPAP provided by a facemask was given for all infants and PPV via facemask was only initiated if: (1) bradycardia occurred after more than 90 seconds after cord clamping, or (2) spontaneous breathing activity was not sufficient to achieve a target range of SpO 2 after 5 minutes of life. Intubation followed by surfactant administration was indicated when PPV with PEEP was required for more than 6 minutes. FiO 2 was commenced at 0.30 and was subsequently titrated in 0.1e0.20 increments every 30e60 seconds if (1) the preductal SpO 2 value was outside of a defined time-related range (an increasing trend between 60-85% at 2e6 minutes, then between 80e93%), or (2) HR <100/minute persisted for more than 1 minute after the initiation of PPV. If bradycardia <60/ minute lasted for more than 30 seconds, a switch to the use of FiO 2 !0.80 was suggested.
Data collection and statistical analysis
All FiO 2 settings, HR and SpO 2 values, and all interventions were assessed and tabulated in 15-second intervals from the collected video recordings of each patient by a single unbiased independent physician who was not involved in the actual resuscitations. All individual incremental increases of FiO 2 , performed during the 6 minutes after cord clamping, and the related changes of HR and SpO 2 during the subsequent four 15-second intervals were identified and statistically evaluated in all patients. These data were then compared between the two EPI groups; all infants were divided according to the extent of ventilatory support required: the CPAP group only received CPAP and the PPV group received CPAP and positive pressure inflations. Because the data were collected in 15-second intervals, each incremental increase of FiO 2 ðDFiO ) in all infants and in the two groups separately. The nonparametric Mann-Whitney U and Wilcoxon tests were used to compare related changes between the two groups of infants. The Pearson Chi-square test and the Fisher exact test were used for categorical variables. In post hoc analysis we used Kruskal-Wallis analysis to test the effect of the extent of DFiO 
Results
Of the 65 EPIs <29 weeks live-born during the investigational period, 43 EPIs could be enrolled in this study because of different technical difficulties with the extraction of the recorded data: 14 of these were supported by facemask CPAP exclusively, followed by nasal CPAP, and the remaining 29 required PPV (with PEEP) during the first 6 minutes of life. The basic clinical characteristics and delivery room interventions are summarized in Tables 1 and 2 . Only 3 of 14 infants (21%) were initially bradycardic <100/ minute in the CPAP group, although spontaneous breathing activity was present. In infants requiring PPV, bradycardia <100/minute and/or poor spontaneous breathing activity was the reason for initiation of PPV at the median time (IQR) of 114 seconds (72e150 seconds). In 18 of 29 infants (62%), bradycardia was present in the first clear PO measurement. Within the first 6 minutes of life, 731 measurements of HR as well as SpO 2 in 15-second intervals could be analyzed, 493 in the PPV group and 238 in the CPAP group. Together we found 336 of 731 hypoxemic measurements (46%; below the 10th percentile), 12 42 of 336 (12%) in the CPAP group and 294/336 (88%) in the PPV group (p < 0.001). Only 40 of 731 hyperoxemic measurements (5%; SpO 2 > 93%) were found in all infants, 34 of 40 (85%) in the CPAP group and 6 of 40 (15%) in PPV group (p < 0.001).
Seventy-seven incremental increases of FiO 2 were required in 37 of the infants (86%): 26 (34%) were required in 10 infants (71%) in the CPAP group, whereas 27 infants (93%) in the PPV group required 51 incremental increases in FiO 2 (68%). Only seven episodes of a direct switching of FiO 2 to !0.80 were identified, all of which were in the PPV group. The characteristics of all incremental increases of FiO 2 and those related to each group are shown in Table 2 . Table 3 .
Post hoc analysis in PPV group
Despite the nonsignificant correlation between the DFiO 
Discussion
During the transition from placental to lung breathing the establishment and the maintenance of alveolar expansion is the first step to oxygenation. This is a dynamic process following delivery and may be influenced by intrinsic variables such as lung maturation, prenatal infection, and the level of spontaneous breathing activity, as well as by extrinsic variables such as the level of the resuscitator's skill, iatrogenic airway obstruction, and mask leak. This observational study shows the different efficacy of incremental increases in FiO 2 in the two groups of extremely preterm infants with different levels of spontaneous breathing activity requiring a different extent of ventilatory support to establish their functional residual capacity during the first 6 minutes of life.
We found that the incremental increases of FiO 2 had a significant effect on the improvement in SpO 2 within 45 seconds when the infants were breathing spontaneously on facemask CPAP only. In this group of infants, 18% (42 of 238) of the 15-second interval measurements of SpO 2 were below the 10th percentile and 14% (34 of 238) of measurements had SpO 2 > 93%. Nearly 70% of the measurements of SpO 2 were within target range (the 25the75th percentile of SpO 2 nomogram) during the first 6 minutes of life. 12 Interestingly, in this small CPAP group of extremely premature infants, the medians and IQRs of HR and SpO 2 at 5 minutes correspond very closely to the reference ranges according to Dawson et al 12 [147 beats per minute (bpm); (135e156) vs. 156 (142e171); 87% (78e92) vs. 86% (80e92)], where 468 neonates with gestational ages from 25 weeks to 42 weeks (only 24% of preterm infants <32 weeks) without any DR interventions were recruited. In a recently published study, Vento et al 13 showed that well-adapted spontaneously breathing very preterm infants can be managed with CPAP via facemask with air and achieve the SpO 2 reference ranges of Dawson et al's 12 nomograms even earlier. Spontaneously breathing very preterm infants prolong their expiration by braking their expiratory flow against a closed or narrowed glottis and thus increase intrapulmonary pressure above atmospheric pressure. This biological force facilitates the clearing of fluid from the lung, resulting in better distribution of gas and opening of the alveoli. 9 This finding is consistent with the good SpO 2 response after incremental FiO 2 increases in our CPAP group. Despite the small sample size of our CPAP group, we think that a certain proportion of extremely premature infants with some spontaneous breathing effort can also be safely managed by CPAP via mask during the first minutes of life with effective gentle tailoring of FiO 2 and achieve the same reference ranges of oxygen saturation as the more mature infants.
The incremental increases of FiO 2 did not, however, increase either SpO 2 or HR values significantly in the infants who had poor spontaneous breathing activity requiring PPV despite the higher mean level of FiO 2 prior to incremental increase to an even larger extent. These differences in FiO 2 tailoring could be explained by mostly larger incremental increases of FiO 2 performed by specialists in the recommended range of 0.1e0.2 (14% of them were identified as the direct switches to FiO 2 ! 0.8). The longer median time of mean FiO 2 incremental increases in PPV group corresponds well with the chronological order of our interventions described in resuscitation procedure. First, CPAP via mask was switched to PPV and then the first incremental increase of FiO 2 followed if bradycardia persisted. In this group of infants, 60% (294 of 493) of the SpO 2 measurements were below the 10 th percentile during the first 6 minutes of life. 12 These infants did not respond well to facemask PPV managed by our specialists and finally 41% of them required intubation at the median time (IQR) of 378 (348e389) seconds after delivery. They were significantly more immature, had a lower rate of full antenatal steroid treatment, and had lower Apgar scores at the 1st minute and 5th minute.
In a post hoc analysis the larger extent of the incremental increases of FiO 2 was found effective in improving oxygenation with a borderline significance, but when higher initial levels of FiO 2 were used the significantly larger SpO 2 changes were found. This dose-related effect of the initial level of FiO 2 is also time-related and the synergic effect of a higher dose of oxygen and advanced lung aeration may play a role in better oxygenation. These findings correspond well with the significantly longer time needed to achieve stable HR and SpO 2 in this group of EPI. The PPV using Manual inflations were performed mostly with a short inflation time, sometimes interrupted by repositioning of the facemask, thereby losing PEEP. The T-piece device was used without changes in the preset pressure and a crossover to self-inflating bag ventilation was not practiced during the first 6 minutes of life. This pattern of artificial breathing together with the common occurrence of leaks and obstructions may delay uniform lung aeration and the establishment of lung volume, which may adversely influence the efficacy of supplemental oxygen. 10 Fuchs et al 14 have shown that a sustained inflation can increase HR rapidly and SpO 2 with slight delay in apneic infants. However, infants in our study did not routinely receive a sustained inflation. Three of five patients increased their HR within 1 minute after one unrepeated 10-second inflation of 25 cmH 2 O. There are several limitations to this study. The infants in the PPV group were more immature, smaller, and sicker and their lungs might have been less developed than those in the CPAP group and required more ventilatory support with poor response to the incremental increases of FiO 2 .
The observational retrospective design of this study does not allow identification of the precise time of incremental increases in FiO 2 performed during the 15-second interval. That means that each incremental increase of FiO 2 could have occurred anytime during this 15-second interval and the subsequent HR and SpO 2 changes are related to this 15-second interval and not to the actual time of the FiO 2 increase. We think that the 45e60-second interval should be long enough for the final evaluation of the effect of oxygen changes. Vento et al 5 and Dawson et al 6 considered an interval of at least 30 seconds to be adequate for the evaluation of the potential effect of oxygen changes. It corresponds well with the 30e45-second time interval during which the first significant related changes of SpO 2 were found in our infants who responded well in our CPAP group.
Furthermore, because obstruction and leak episodes were not measured in our study, we cannot comment on Bpm Z beats per minute; FiO 2 Z fractional inspired oxygen; HR Z heart rate; SpO 2 Z oxygen saturation. * Although significantly higher incremental increases in FiO 2 were performed in the positive pressure ventilation (PPV) group, the significantly higher changes in SpO 2 were found in the continuous positive airway pressure group, which was mainly recognized between 30-second and 45-second intervals after FiO 2 increase. In the same time interval, the HR changes were significantly higher in the PPV group but it was not confirmed during the entire investigational period. values. Mann-Whitney U testing found significant differences between the two groups in independent and both dependent variables at each time point of investigation (p < 0.01). The values are mean with standard deviations. CPAP Z continuous positive airway pressure; FiO 2 Z fractional inspired oxygen; HR Z heart rate; PPV Z positive pressure ventilation; SpO 2 Z oxygen saturation.
whether the attenuated effect of the oxygen increases was caused primarily by the delayed aeration of the lungs in the poorly spontaneously breathing infants or due to the effects of such obstructions and/or leaks.
Another limitation is that PPV was only initiated if bradycardia was present after 90 seconds or target saturations were not reached by 5 minutes. It is possible that earlier initiation of PPV in infants with marginal respiratory effort might be more effective in establishing functional residual capacity and might lead to a better response to incremental increase of FiO 2 .
In conclusion, spontaneous breathing, supported by continuous distending pressure, appears to be the best condition for adequate lung aeration resulting in gradual improvement of oxygenation. These infants can be managed effectively by "gentle" tailoring of FiO 2 in increments of 0.1e0.2 in 30e45-second intervals.
However, when PPV was required in more immature infants who were not initially spontaneously breathing, a much higher incremental increase in FiO 2 was required to improve oxygenation.
Establishment of adequate functional residual capacity should be the primary aim during the first minutes of life in extremely premature infants. The technique of facemask positive pressure ventilation used in this study, which is based on the last ILCOR recommendation, did not achieve adequate lung volume recruitment. Further studies are required in order to determine best ways of lung volume recruitment in infants lacking spontaneous respiratory effort and to accurately guide the administration of FiO 2 during the resuscitation of extremely preterm infants based on the degree of spontaneous respiratory activity.
